Compare Cigna Corp (CI) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs JPMorgan Chase & Co — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while JPMorgan Chase & Co trades at $362.22 (market cap $956.39B). The key difference: JPMorgan Chase & Co is far larger — about 13× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | JPM | |
|---|---|---|
Market Cap | $73.56B | $956.39B |
Sector | Health | Financials |
52-Week High | $311.00 | $359.79 |
52-Week Low | $244.41 | $282.84 |
Enterprise Value | $98.27B | — |
Dividend Yield | 2.24% | 1.67% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
JPMorgan Chase & Co. (JPM) trades at $362.04, up 1.26% in the last session, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $374.18. Recent earnings beat expectations in Q1 and Q2 2026, with Q3 2026 results pending. The company maintains strong profitability metrics, including a net income margin of 33.38% and ROE of 18.43%, though cash flow trends show volatility amid macroeconomic uncertainties.
The stock presents a moderate buy opportunity with upside potential from earnings resilience and sector strength, but risks include geopolitical tensions, cybersecurity threats highlighted in recent news, and fluctuating cash flows. Investors should weigh analyst optimism against CEO warnings on economic challenges for balanced decision-making.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
